| Literature DB >> 32947958 |
Muhammad Babar Taj1,2, Muneera D F Alkahtani3, Uzma Ali4, Ahmad Raheel4, Walla Alelwani5, Afnan M Alnajeebi5, Nouf Abubakr Babteen5, Sadia Noor6, Heba Alshater7.
Abstract
The microbial resistance to current antibiotiEntities:
Keywords: antimicrobial; electronic spectroscopy; micellar solubilization; mixed chelation; stability constants
Year: 2020 PMID: 32947958 PMCID: PMC7570477 DOI: 10.3390/molecules25184252
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthesis of aldimine ligands (HL1–HL3) and metal complexes.
Electronic spectral data of ligands (HL1–3) and heteroleptic complexes (ML1–3Gly).
| Compound | Electronic Absorption Peaks (nm) | Type of Transition |
|---|---|---|
| HL1 | 347 | n→π*, π→π* |
| CoL1Gly | 724, 349.2, 262 | d-d, CT |
| NiL1Gly | 734, 348.2, 258 | d-d, π→π*, n→π |
| CuL1Gly | 734, 348.5, 260 | d-d, π→π* |
| ZnL1Gly | 349 | Intra-ligand transition |
| HL2 | 441, 358 | n→π* |
| CoL2Gly | 690, 476, 456 | d-d, CT (charge transfer) |
| NiL2Gly | 675, 507, 406, 303, 262 | d-d, CT, n→π*, π→π* |
| CuL2Gly | 680, 532, 441, 426 | d-d, CT |
| ZnL2Gly | 445 | Intra-ligand transition |
| HL3 | 334, 276 | n→π*, π→π* |
| CoL3Gly | 732, 419, 332, 256, 246 | d-d, CT, n→π*, π→π* |
| NiL3Gly | 640, 475, 377, 308, 246, 207 | d-d, CT, n→π*, π→π* |
| CuL3Gly | 657, 439 | d-d, Intra-ligand, n→π* |
| ZnL3Gly | 402, 293 | Intra-ligand transition |
Stability Constants of heteroleptic complexes (ML1–3Gly).
| Compound | Kst (kJ/mol) | Compound | Kst (kJ/mol) | Compound | Kst (kJ/mol) |
|---|---|---|---|---|---|
| CoL1Gly | 5.47 × 1012 | CoL2Gly | 1.65 × 1012 | CoL3Gly | 3.34 × 1013 |
| NiL1Gly | 1.78 × 1011 | NiL2Gly | 1.75 × 1012 | NiL3Gly | 4.58 × 1012 |
| CuL1Gly | 1.9 × 109 | CuL2Gly | 7.5 × 107 | CuL3Gly | 6.25 × 105 |
| ZnL1Gly | 2.95 × 1010 | ZnL2Gly | 8.21 × 108 | ZnL3Gly | 1.22 × 105 |
Antibacterial data of HL1–3, Gly and their heteroleptic complexes at 1 mg/mL concentration.
| Compound | Minimum Zone of Inhibition (mm) | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| HL1 | 24.5 | 17.3 | 27.3 | 17.3 | 13.9 | 16.8 |
| HL2 | 22.3 | 16.2 | 24.9 | 16.5 | 14.6 | 19.4 |
| HL3 | 24.1 | 15.5 | 23.6 | 18.4 | 16.1 | 20.3 |
| Gly | 14.9 | 13.2 | 23.0 | 11.5 | 13.7 | 17.0 |
| CoL1Gly | 31.0 | 19.5 | 24.4 | 18.6 | 20.1 | 26.0 |
| NiL1Gly | 29.0 | 21.0 | R | R | 23.0 | 18.5 |
| CuL1Gly | 21.0 | 28.5 | 21.5 | 23.1 | 23.0 | 27.3 |
| ZnL1Gly | 27.7 | 23.0 | 23. 6 | 30.3 | 14.1 | 18.3 |
| CoL2Gly | 28.0 | 18.0 | 21.9 | 17.3 | 19.1 | 21.0 |
| NiL2Gly | 26.9 | 20.3 | R | R | 21.5 | 27.6 |
| CuL2Gly | 19.2 | 24.1 | 22.9 | 24.0 | 23.0 | 26.0 |
| ZnL2Gly | 26.1 | 22.4 | 22.2 | 28.8 | 17.1 | 16.0 |
| CoL3Gly | 32.2 | 21.6 | 24.4 | 18.6 | 20.1 | 28.1 |
| NiL3Gly | 30.3 | 23.6 | R | R | 25.4 | 30.0 |
| CuL3Gly | 23.1 | 29.7 | 23.1 | 25.0 | 26.2 | 29.2 |
| ZnL3Gly | 27.4 | 24.4 | 25.1 | 32.1 | 16.4 | 18.3 |
| + Ciprofloxacin | 33.0 | 32.0 | 36.0 | 26.0 | 29.0 | 23.0 |
| –(CH3)2SO | R | R | R | R | R | R |
R: No bacterial growth inhibition was observed; +: standard drug.
Figure 1Antibacterial activity of CoL1Gly against different bacterial strains.
Antifungal data of HL, Gly and Gly’s heteroleptic complexes at 1 mg/mL concentration.
| Compound | Minimum Zone of Inhibition (mm) | ||
|---|---|---|---|
|
|
|
| |
| HL1 | 22.7 | 28.7 | 26.3 |
| HL2 | 23.2 | 29.1 | 29.4 |
| HL3 | 24.7 | 27.6 | 28.6 |
| Gly | 16.0 | 19.8 | 13.6 |
| CoL1Gly | 25.6 | 24.1 | 26.5 |
| NiL1Gly | 14.5 | 24.2 | – |
| CuL1Gly | 22.2 | 24.1 | 24.7 |
| ZnL1Gly | 17.3 | 25.3 | – |
| CoL2Gly | 24.6 | 29.3 | 27.9 |
| NiL2Gly | 14.4 | 23.1 | – |
| CuL2Gly | 24.2 | 24.5 | 26.1 |
| ZnL2Gly | 13.0 | 26.0 | – |
| CoL3Gly | 25.1 | 27.1 | 28.6 |
| NiL3Gly | 16.5 | 24.1 | – |
| CuL3Gly | 23.9 | 27.5 | 25.5 |
| ZnL3Gly | 18.0 | 28.1 | – |
| + Fluconazole | 36.0 | 29.0 | 39.3 |
| –(CH3)2SO | – | – | – |
+: standard drug.
Figure 2Plots of conductivity and differential conductivity vs. (sodium lauryl sulfate) SLS concentrations.
Calculated micellar parameter for the interaction of complexes with SLS.
| System | CMC (mM) | ∆Gm (kJ/mol) | β |
|---|---|---|---|
| SLS | 8.3 | −38.39 | 0.243 |
| CoL1Gly/SLS | 10.52 | −33.79 | 0.426 |
| CoL2Gly/SLS | 9 | −28.11 | 0.7 |
| CoL3Gly/SLS | 9.56 | −27.11 | 0.737 |
| NiL3Gly/SLS | 10.83 | −31.072 | 0.532 |
Figure 3Plots of simple and differential absorbance vs. SLS concentrations.
Partitioning and binding parameters of selected complexes in micellar media.
| Complex | Kx (dm3/mol) | ∆Gp (kJ/mol) | Kb (dm3/mol) | ∆Gb (kJ/mol) |
|---|---|---|---|---|
| CoL1Gly | 137 | −12.19 | 190 | −13 |
| CoL2Gly | 27,400 | −25.31 | 325 | −14.25 |
| CoL3Gly | 50,000 | −26.8 | 58.5 | −10.08 |
| NiL3Gly | 956 | −17 | 80 | −10.85 |
Figure 4Proposed locus of metal complexes in the micelles of SLS.